C57BL/6JCya-Gartem1flox/Cya
Common Name
Gart-flox
Product ID
S-CKO-18707
Backgroud
C57BL/6JCya
Strain ID
CKOCMP-14450-Gart-B6J-VB
When using this mouse strain in a publication, please cite “Gart-flox Mouse (Catalog S-CKO-18707) were purchased from Cyagen.”
Product Type
Age
Genotype
Sex
Quantity
Basic Information
Strain Name
Gart-flox
Strain ID
CKOCMP-14450-Gart-B6J-VB
Gene Name
Product ID
S-CKO-18707
Gene Alias
Gaps, Prgs
Background
C57BL/6JCya
NCBI ID
Modification
Conditional knockout
Chromosome
Chr 16
Phenotype
Datasheet
Application
--
Strain Description
Ensembl Number
ENSMUST00000023684
NCBI RefSeq
NM_010256
Target Region
Exon 3~4
Size of Effective Region
~1.0 kb
Overview of Gene Research
Gart, or glycinamide ribonucleotide transformylase, is a trifunctional polypeptide with phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, and phosphoribosylaminoimidazole synthetase activity. It is essential for de novo purine biosynthesis and is highly conserved in vertebrates [3]. Gart is involved in multiple signaling pathways, such as the Wnt/β -catenin pathway, and plays a significant role in various biological processes and disease conditions.
In colorectal cancer, Gart has a novel methyltransferase function. Its enzymatic activity center is at the E948 site, and it enhances the stability of RUVBL1 through methylating its K7 site, aberrantly activating the Wnt/β -catenin signaling pathway to promote tumor stemness. Pemetrexed, a GART -targeting compound, combined with other chemotherapy drugs can suppress tumor growth [1]. In multiple myeloma, GART promotes malignancy via tumor stemness by activating the HSP90α/CDK6/β -catenin axis, and its inhibitor pemetrexed can suppress cell proliferation and tumor growth [4]. In non-small cell lung cancer, GART promotes cell proliferation and migration by targeting the PAICS-Akt-β -catenin pathway [7]. In luminal A ERα-expressing breast cancer, inhibition of GART induces ERα degradation and prevents cell proliferation, and GART inhibitors can be a novel strategy for treating primary and metastatic breast cancers [8].
In Drosophila, Gart is expressed in the glia, fat body, and gut, positively regulating feeding behavior and energy homeostasis [2]. In rat spinal cord injury, GART expression changes dynamically, and its knockdown in astrocytes affects the release of pro-inflammatory factors [3]. In colitis, GART mediates the renewal of the intestinal epithelial barrier via the p38/p53/PUMA cascade [5]. Also, VGLL3 in cancer cells increases the dependency on de novo nucleotide synthesis by inducing GART expression [6].
In conclusion, Gart is crucial for de novo purine biosynthesis and is involved in multiple biological processes and diseases. Studies, including those using potential gene-knockout or other loss-of-function models, have revealed its role in cancer development, feeding behavior, energy homeostasis, inflammation, and epithelial barrier renewal. Targeting Gart shows promise as a therapeutic strategy for several cancers and may offer new insights into treating other related diseases.
References:
1. Tang, Chao, Ke, Mengying, Yu, Xichao, Gu, Chunyan, Yang, Ye. 2023. GART Functions as a Novel Methyltransferase in the RUVBL1/β-Catenin Signaling Pathway to Promote Tumor Stemness in Colorectal Cancer. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 10, e2301264. doi:10.1002/advs.202301264. https://pubmed.ncbi.nlm.nih.gov/37439412/
2. He, Lei, Wu, Binbin, Shi, Jian, Du, Juan, Zhao, Zhangwu. 2023. Regulation of feeding and energy homeostasis by clock-mediated Gart in Drosophila. In Cell reports, 42, 112912. doi:10.1016/j.celrep.2023.112912. https://pubmed.ncbi.nlm.nih.gov/37531254/
3. Zhang, Dongmei, Yue, Ying, Jiang, Shengyang, Tao, Tao, Gu, Xingxing. 2014. GART expression in rat spinal cord after injury and its role in inflammation. In Brain research, 1564, 41-51. doi:10.1016/j.brainres.2014.03.044. https://pubmed.ncbi.nlm.nih.gov/24709117/
4. Qian, Jinjun, Meng, Han, Wang, Ze, Yang, Ye, Gu, Chunyan. 2025. GART promotes multiple myeloma malignancy via tumor stemness mediated by activating the HSP90α/CDK6/β-catenin axis. In European journal of pharmacology, 996, 177584. doi:10.1016/j.ejphar.2025.177584. https://pubmed.ncbi.nlm.nih.gov/40185325/
5. Bai, Jian-An, Jie, Hua, Wei, Sun, Guo, Huarui, Tang, Qiyun. . GART mediates the renewal of intestinal epithelial barrier via p38/p53/PUMA cascade in colitis. In Apoptosis : an international journal on programmed cell death, 21, 1386-1397. doi:. https://pubmed.ncbi.nlm.nih.gov/27718035/
6. Kawamura, Tomohiro, Takehora, Yuki, Hori, Naoto, Takano, Hiroyuki, Yamaguchi, Noritaka. 2022. VGLL3 increases the dependency of cancer cells on de novo nucleotide synthesis through GART expression. In Journal of cellular biochemistry, 123, 1064-1076. doi:10.1002/jcb.30251. https://pubmed.ncbi.nlm.nih.gov/35434822/
7. Chen, Zhuo, Ding, Yu-Heng, Zhao, Mei-Qi, Qian, Xiang, Ji, Xu-Ming. 2025. GART promotes the proliferation and migration of human non-small cell lung cancer cell lines A549 and H1299 by targeting PAICS-Akt-β-catenin pathway. In Frontiers in oncology, 15, 1543463. doi:10.3389/fonc.2025.1543463. https://pubmed.ncbi.nlm.nih.gov/40201340/
8. Cipolletti, Manuela, Leone, Stefano, Bartoloni, Stefania, Acconcia, Filippo. 2023. A functional genetic screen for metabolic proteins unveils GART and the de novo purine biosynthetic pathway as novel targets for the treatment of luminal A ERα expressing primary and metastatic invasive ductal carcinoma. In Frontiers in endocrinology, 14, 1129162. doi:10.3389/fendo.2023.1129162. https://pubmed.ncbi.nlm.nih.gov/37143728/
Quality Control Standard
Sperm Test
Pre-cryopreservation: Measurement of sperm concentration, determination of sperm viability.
Post-cryopreservation: A vial of cryopreserved sperms is selected for in-vitro fertilization from each batch.
Environmental Standards:SPF
Available Region:Global
Source:Cyagen
Contact Us
Connect with our experts for your custom animal model needs. Please fill out the form below to start a conversation or request a quote.
Cyagen values your privacy. We’d like to keep you informed about our latest offerings and insights. Your preferences:
You may unsubscribe from these communications at any time. See our Privacy Policy for details on opting out and data protection.
By clicking the button below, you consent to allow Cyagen to store and process the personal information submitted in this form to provide you the content requested.
